Background The role of coronary-artery bypass grafting (CABG) in the treatment of patients
with coronary artery disease and heart failure has not been clearly established. Methods …

ContextThe association between systolic blood pressure (SBP) at admission, clinical
characteristics, and outcomes in patients hospitalized for heart failure who have reduced or …

Background The assessment of myocardial viability has been used to identify patients with
coronary artery disease and left ventricular dysfunction in whom coronary-artery bypass …

Background The survival benefit of a strategy of coronary-artery bypass grafting (CABG)
added to guideline-directed medical therapy, as compared with medical therapy alone, in …

Aims Hyponatraemia has been shown to be an independent predictor of mortality in selected
patients with heart failure enrolled in clinical trials. The predictive value of hyponatraemia …

Background Ferric carboxymaltose therapy reduces symptoms and improves quality of life
in patients who have heart failure with a reduced ejection fraction and iron deficiency. …

Background Experimental studies and small clinical trials have suggested that treatment with
intranasal oxytocin may reduce social impairment in persons with autism spectrum disorder…

Importance Patients with heart failure and preserved ejection fraction (HFpEF) are at high
risk of mortality, hospitalizations, and reduced functional capacity and quality of life. Objective …

Background— Whether mitral valve repair during coronary artery bypass grafting (CABG)
improves survival in patients with ischemic mitral regurgitation (MR) remains unknown. …

Anemia in heart failure (HF) is increasingly recognized and treated, but little is known about
the prevalence and its relation to outcomes in patients hospitalized for decompensated HF in …